Literature DB >> 15792284

Long-term monitoring of the mortality trend of Huntington's disease in Austria.

Eva Ekestern1, Gustav Lebhart.   

Abstract

Recent increasing incidence and prevalence rates of Huntington's disease (HD), a fatal neurodegenerative disorder, prompted us to investigate the epidemiological dynamic of HD in Austria during the period 1970--2001. Our study demonstrated a stable HD mortality rate throughout Austria of 0.125 per 100,000 individuals during the investigated period. The median age at death from HD was 56.5 years for both sexes and remained stable during the entire period observed, indicating no prolonged survival. An above average mortality rate from HD was observed in the north-eastern parts of Austria. Our data reflect the epidemiology of HD prior to and after the availability of genetic testing and provide a solid baseline for future investigations on the epidemiology of HD.

Entities:  

Mesh:

Year:  2005        PMID: 15792284     DOI: 10.1007/s10654-004-4658-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

Review 1.  Apoptosis and caspases in neurodegenerative diseases.

Authors:  Robert M Friedlander
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

2.  Differences in duration of Huntington's disease based on age at onset.

Authors:  T Foroud; J Gray; J Ivashina; P M Conneally
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

3.  The prevalence of Huntington's disease in Tasmania.

Authors:  S A Pridmore
Journal:  Med J Aust       Date:  1990-08-06       Impact factor: 7.738

4.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 5.  Juvenile onset Huntington's disease--clinical and research perspectives.

Authors:  M A Nance; R H Myers
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2001

6.  High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.

Authors:  E W Almqvist; D S Elterman; P M MacLeod; M R Hayden
Journal:  Clin Genet       Date:  2001-09       Impact factor: 4.438

7.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

8.  DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland.

Authors:  F Laccone; U Engel; E Holinski-Feder; M Weigell-Weber; K Marczinek; D Nolte; D J Morris-Rosendahl; C Zühlke; K Fuchs; H Weirich-Schwaiger; G Schlüter; G von Beust; A M Vieira-Saecker; B H Weber; O Riess
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

9.  Family history and DNA analysis in patients with suspected Huntington's disease.

Authors:  S Siesling; M Vegter-van de Vlis; M Losekoot; R D Belfroid; J A Maat-Kievit; H P Kremer; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

10.  Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease.

Authors:  E W Almqvist; R R Brinkman; S Wiggins; M R Hayden
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

View more
  1 in total

1.  Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain.

Authors:  Esther Vicente; Ainara Ruiz de Sabando; Fermín García; Itziar Gastón; Eva Ardanaz; María A Ramos-Arroyo
Journal:  Orphanet J Rare Dis       Date:  2021-02-10       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.